Agilent Technologies에 대한 매도 수량은 투자자에게 Agilent Technologies의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Agilent Technologies (NYSE:A) 주식, 공매도 수량 보고

Agilent Technologies

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

Equities

Large Cap

News

Movers

General

CELH

DKNG

NTNX

SNOW

지난주 이들 10개 대형주는 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 몽고DB(NASDAQ:MDB) 주식은 약한 2분기 및 2025회계연도 가이던스 발표 후 31.63% 급락했다. 이에 따라 애널리스트들이 주식의 목표가를 낮췄다. 

세일즈포스와 셀시우스는 지난주 최악의 성과를 보인 10개의 대형주 중 일부

Earnings

After-Hours Center

애질런트 테크놀로지스(NYSE:A)의 주가는 회사의 2분기 재무 결과에 따라 수요일 시장 마감 후 하락했다. 애질런트는 느린 시장 회복을 반영하여 연간 전망을 수정했다. 2분기 매출: 15억 달러로, 예상치 15.8억 달러와 비교 2분기 EPS: 1.22달러, 예상치 1.19달러와 비교

애질런트 테크놀로지스: 부진한 2분기 매출과 약한 3분기 실적 전망 발표 후 주가 급락

Agilent Technologies Inc

Alcoa Corp

AIR ASTANA JOINT STOCK GDR 144A

Alternative Access First Priority CLO Bond ETF

Aareal Bank AG Registered Shares

AAREAL BANK N ORD

AAREAL BANK AG UNSP/ADR by Aareal Bank AG

Aareal Bank AG

Goldman Sachs Physical Gold ETF Shares

AAX Token

ASIA BROADBAND INC by Asia Broadband, Inc.

Asia Broadband Inc

ABERDEEN INTL INC by Aberdeen International Inc.

Aberdeen International Inc

ARES ACQUISITION CORP CL A ORD SHS

Double-A Chain

AAC TECHS HLDGS INC ORD by AAC Technologies Holdings Inc

AAC Technologies Holdings Inc

AAC TECHS HLDGS UNSP/ADR by AAC Technologies Holdings Inc

Alexandria Agtech/Climate Innovation Acquisition Corp.

ATA Creativity Global - American Depositary Shares, each representing two common shares

ATA Creativity Global

Armada Acquisition Corp I

Armada Acquisition Corp I Units (1 Ord & 1/2 War)

Armada Acquisition Corp I Warrants (13/08/2026)

Advancit Acquisition Corp. I

Aeon Acquisition Corp

AMER COMMERCE SOLTNS INC by American Commerce Solutions, Inc.

American Commerce Solutions Inc

Ares Acquisition Corporation II Class A Ordinary Shares

Ares Acquisition Corp II

Ares Acquisition Corporation II Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant

Ares Acquisition Corporation II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50

AURORA SOLAR TECHNOLOGIES by Aurora Solar Technologies Inc.

Aurora Solar Technologies Inc

Aadi Bioscience Inc

AdvisorShares Dorsey Wright ADR ETF

Altair Resources Inc

Airtel Africa PLC

ALL AMERICAN GOLD CORP by All American Gold Corp.

All American Gold Corp

AFTERMATH SILVER LTD ORD by Aftermath Silver Ltd.

Aftermath Silver Ltd

AMERICA GREAT HEALTH by America Great Health

America Great Health

AIA Group Ltd

AFRICAN AGRI HLDGS INC by African Agriculture Holdings Inc.

African Agriculture Holdings Inc

African Agriculture Holdings Inc Warrants (06/12/2028)

ASTRA AGRO LESTR UNSP/ADR by Astra Agro Lestari TBK

PT Astra Agro Lestari Tbk

Asahi Co Ltd

ALABAMA AIRCRAFT INDUS by Alabama Aircraft Industries, Inc.

Alabama Aircraft Industries Inc

Arlington Asset Investment Corp 6.000% Sr Nt 08/01/2026

American Aires Inc Ordinary Shares

AMERICAN AIRES INC by American Aires Inc.

American Aires Inc

AAK AB

American Airlines Group, Inc. - Common Stock

American Airlines Group Inc

AALBERTS INDUS NV ORD by A. Alberts Industries

Aalberts NV

AALBERTS ORD

AMERICAN AIRLINES GROUP ORD

AA Mission Acquisition Corp. Class A Ordinary Shares

AA Mission Acquisition Corp

AA Mission Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant

AA Mission Acquisition Corp. Warrants, each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share

ATLAS MARA CO NVEST ORD by Atlas Mara Co Nvest Ltd.

Atlas Mara Ltd

Altisource Asset Management Corp Com

ALTISOURCE ASSET MGMT by Altisource Asset Management Corp

Altisource Asset Management Corp

Atlantic American Corporation - Common Stock

Atlantic American Corp

ALMADEX MINERALS LTD by Almadex Minerals Ltd.

Almadex Minerals Ltd

ARMADA MERCANTILE LTD by Armada Mercantile Ltd.

Armada Mercantile Ltd

The Aarons Co Inc

Aroundtown SA

Applied Optoelectronics, Inc. - Common Stock

Applied Optoelectronics Inc

APPLIED OPTOELECTRONICS ORD

AAON Inc

Advance Auto Parts Inc

GraniteShares 2x Long AAPL Daily ETF

Direxion Daily AAPL Bear 1X Shares

APPLE ISPORTS GROUP INC by Apple iSports Group Inc.

Apple iSports Group Inc

AAP Inc

Apple Inc

APPLE ORD

SHL Telemedicine Ltd Innovator Equity Defined Protection ETF - 2 Yr to April 2026

ALL AMERICAN PET CO INC by All American Pet Company, Inc.

Kuora Inc

Direxion Daily AAPL Bull 2X Shares

ETF Opportunities Trust T-Rex 2X Long Apple Daily Target ETF

NEOS ETF Trust Kurv Yield Premium Strategy Apple (AAPL) ETF

ANTIAGING QNTUM LGN A by Antiaging Quantum Living Inc.

Antiaging Quantum Living Inc

AIRTEL AFRICA PLC ADR by Airtel Africa Plc

ABERDEEN ASIAN SMALLR COS by Aberdeen Asian Smaller Companies Investment Trust Plc

Aberdeen Asian Smaller Co Investment Trust Plc

AMERICA'S SUPPLIERS INC by America's Suppliers, Inc.

ASIA AIR SURVEY CO LTD by ASIA AIR SURVEY CO LTD.

Asia Air Survey Co Ltd

GLOBAL ACQUISITIONS CORP by Global Acquisitions Corporation

Global Acquisitions Corp

AMUNDI ETF EM AS B ETF

In the preceding three months, 9 analysts have released ratings for Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>), presenting a wide array of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $149.33, a high estimate of $165.00, and a low estimate of $135.00. Marking an increase of 7.73%, the current average surpasses the previous average price target of $138.62. 
<img src="https://www.benzinga.com/files/images/story/2024/1727802026_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Agilent Technologies. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vijay Kumar</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$145.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Brandon Couillard</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Overweight</td>
<td>$157.00</td>
<td>-</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$135.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Elizabeth Garcia</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$150.00</td>
<td>$141.00</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$165.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Dan Brennan</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$160.00</td>
<td>$153.00</td>
</tr>
<tr>
<td>Vijay Kumar</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$135.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Derik De Bruin</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$147.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$150.00</td>
<td>$135.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Agilent Technologies. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Agilent Technologies compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
For valuable insights into Agilent Technologies's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/A/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Agilent Technologies analyst ratings.</a>
<h2>About Agilent Technologies</h2>
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.
<h3>A Deep Dive into Agilent Technologies's Financials</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Negative Revenue Trend: Examining Agilent Technologies's financials over 3 months reveals challenges. As of 31 July, 2024, the company experienced a decline of approximately -5.62% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 17.87%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Agilent Technologies's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.65% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.58%, the company showcases effective utilization of assets.
Debt Management: Agilent Technologies's debt-to-equity ratio is below the industry average. With a ratio of 0.5, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Basics of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Analyst Ratings For Agilent Technologies

Evercore ISI Group analyst Vijay Kumar maintains Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) with a In-Line and raises the price target from $135 to $145.

Price Target

Evercore ISI Group Maintains In-Line on Agilent Technologies, Raises Price Target to $145

Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) has outperformed the market over the past 20 years by 1.28% on an annualized basis producing an average annual return of 9.75%. Currently, Agilent Technologies has a market capitalization of $40.57 billion. 
Buying $100 In A: If an investor had bought $100 of A stock 20 years ago, it would be worth $642.18 today based on a price of $141.19 for A at the time of writing.
<h3>Agilent Technologies's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727109010_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $100 Invested In Agilent Technologies 20 Years Ago Would Be Worth Today

It has been about a month since the last earnings report for Agilent Technologies (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/a#NYSE">A</a>). Shares have added about 1.2% in that time frame, underperforming the S&amp;P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Agilent due for a pullback? Before we dive into how investors and analysts have reacted as of late, let&#39;s take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
<h3>Agilent Q3 Earnings Beat Estimates</h3>
Agilent Technologies has delivered third-quarter fiscal 2024 earnings of $1.32 per share, which beat the Zacks Consensus Estimate by 5.6%. However, the bottom line decreased 8% from the year-ago quarter.
Revenues of $1.58 billion beat the Zacks Consensus Estimate of $1.56 billion. The top line declined 5.6% on a reported basis and 4.4% on a core basis from the year-ago quarter.
The decline was attributed to broad-based weakness across the Pharma, Food, Chemical and Advanced Materials, and Academic and Government markets.
Weak momentum in China was another concern.
Nevertheless, the company witnessed improvements in the Diagnostics and Clinical, and Environmental and Forensics markets in the reported quarter.
<h3>Segmental Top-Line Details</h3>
Agilent has three reporting segments &mdash; Life Sciences &amp; Applied Markets Group (&quot;LSAG&quot;), Agilent Cross Lab Group (&quot;ACG&quot;), and Diagnostics and Genomics Group (&quot;DGG&quot;).
LSAG: The segment accounted for $782 million or 50% of the company&#39;s total revenues, down 8% on a reported basis and 7% on a core basis from the prior-year quarter. This was due to softness in the instrument business, and weakening momentum across all the geographic regions and end markets, except for Environmental and Forensics. The reported figure missed the Zacks Consensus Estimate of $849 million.
ACG: Revenues from the segment were $411 million, accounting for 26% of the total revenues. The figure surpassed the consensus mark of $385 million. The top line improved 4% from the prior-year quarter on a reported basis and rose 5% on a core basis. This was driven by strong growth in service contract revenues. Growing momentum across all geographic regions, except for China, was a positive.
DGG: Revenues decreased 9% year over year on a reported and 8% on a core basis to $385 million, accounting for the remaining 24% of the total revenues. The figure beat the consensus mark of $332 million. Sluggishness in Genomics, Cell Analysis and NASD was concerning.
<h3>Operating Results</h3>
For the fiscal third quarter, the gross margin in the LSAG segment expanded by 10 basis points (bps) to 60.2% from the prior-year quarter. ACG&#39;s gross margin expanded by 120 bps to 52.1%. DGG&#39;s gross margin contracted 170 bps year over year to 51.8%.
Research and development (&quot;R&amp;D&quot;) expenses were $127 million, up 7.6% from the prior-year quarter. Selling, general and administrative (&quot;SG&amp;A&quot;) expenses were $395 million, down 2.9% from the year-earlier quarter. As a percentage of revenues, R&amp;D expenses expanded by 90 bps year over year to 8%, whereas SG&amp;A expenses increased 70 bps year over year to 25%.
The operating margin for the fiscal third quarter was 21.1%, which expanded significantly from 7.9% in the year-earlier quarter.
Segment-wise, the operating margin in the LSAG segment contracted by 260 bps to 28.4% from the prior-year quarter. ACG&#39;s operating margin expanded by 130 bps year over year to 34%. DGG&#39;s operating margin contracted 440 bps year over year to 18.3%.
<h3>Balance Sheet</h3>
As of Jul 31, 2024, Agilent&#39;s cash and cash equivalents were $1.78 billion, up from $1.67 billion as of Apr 30, 2024.
Accounts receivables were $1.23 billion at the end of third-quarter fiscal 2024 compared with $1.25 billion at the end of second-quarter fiscal 2024.
The long-term debt was $2.137 billion for the reported quarter compared with $2.136 billion in the prior quarter.
<h3>Guidance</h3>
For the fourth quarter of fiscal 2024, management expects revenues of $1.641-$1.691 billion, suggesting a decline of 2.8% to an increase of 0.2% on a reported basis and a decrease of 1.9% to a rise of 1.1% on a core basis from the year-ago quarter&#39;s actuals.
Non-GAAP fiscal fourth-quarter earnings per share are expected to be $1.38-$1.42.
For fiscal 2024, management revised its revenue guidance from $6.42-$6.50 billion to $6.45-6.50 billion, implying a fall of 5.6-4.9% on a reported basis and 5-4.3% on a core basis from the fiscal 2023 reported figure.
The company also revised fiscal 2024 non-GAAP earnings per share guidance from $5.15-$5.25 to $5.21-5.25.
<h2>How Have Estimates Been Moving Since Then?</h2>
In the past month, investors have witnessed a downward trend in estimates review.
<h2>VGM Scores</h2>
Currently, Agilent has an average Growth Score of C, a grade with the same score on the momentum front. Charting a somewhat similar path, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren&#39;t focused on one strategy, this score is the one you should be interested in.
<h2>Outlook</h2>
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Agilent has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
<a href="https://www.zacks.com/stock/news/2339321/why-is-agilent-a-up-1-2-since-last-earnings-report?cid=CS-BENZ-FT-realtime_blog-2339321">To read this article on Zacks.com click here.</a>

Earnings Beats

Guidance

Management

Markets

Tech

Why Is Agilent Up 1.2% Since Last Earnings Report?

Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) has outperformed the market over the past 20 years by 1.01% on an annualized basis producing an average annual return of 9.47%. Currently, Agilent Technologies has a market capitalization of $39.66 billion. 
Buying $100 In A: If an investor had bought $100 of A stock 20 years ago, it would be worth $609.31 today based on a price of $138.02 for A at the time of writing.
<h3>Agilent Technologies's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726497022_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Agilent Technologies's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) short percent of float has fallen 18.84% since its last report. The company recently reported that it has 2.86 million shares sold short, which is 1.12% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.9 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Agilent Technologies Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1725391815_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Agilent Technologies has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Agilent Technologies's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Agilent Technologies's peer group average for short interest as a percentage of float is 5.52%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Peering Into Agilent Technologies's Recent Short Interest

Wells Fargo analyst Brandon Couillard initiates coverage on Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) with a Overweight rating and announces Price Target of $157.

Initiation

Wells Fargo Initiates Coverage On Agilent Technologies with Overweight Rating, Announces Price Target of $157

Ratings for Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) were provided by 18 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $141.83, a high estimate of $165.00, and a low estimate of $125.00. This current average represents a 2.11% decrease from the previous average price target of $144.89. 
<img src="https://www.benzinga.com/files/images/story/2024/1724421653_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Agilent Technologies among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$135.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$165.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Dan Brennan</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$160.00</td>
<td>$153.00</td>
</tr>
<tr>
<td>Vijay Kumar</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$135.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Derik De Bruin</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$147.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$150.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Ross Muken</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$130.00</td>
<td>$126.00</td>
</tr>
<tr>
<td>Derik De Bruin</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$140.00</td>
<td>$134.00</td>
</tr>
<tr>
<td>Brandon Couillard</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$135.00</td>
<td>$152.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$125.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$135.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Dan Brennan</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Buy</td>
<td>$153.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Rachel Vatnsdal</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$155.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Derik De Bruin</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$134.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Elizabeth Garcia</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$141.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Ross Muken</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$126.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Daniel Arias</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$151.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Catherine Schulte</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$136.00</td>
<td>$147.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Agilent Technologies. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Agilent Technologies compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Agilent Technologies's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Agilent Technologies's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/A/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Agilent Technologies analyst ratings.</a>
<h2>Get to Know Agilent Technologies Better</h2>
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.
<h3>Agilent Technologies's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Agilent Technologies displayed positive results in 3 months. As of 31 July, 2024, the company achieved a solid revenue growth rate of approximately 0.32%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.
Net Margin: Agilent Technologies's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 17.87%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Agilent Technologies's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 4.65%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Agilent Technologies's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.58% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Agilent Technologies's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.5.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Critical Insights From Agilent Technologies Analyst Ratings: What You Need To Know

Barclays analyst Luke Sergott maintains Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) with a Underweight and raises the price target from $125 to $135.

Barclays Maintains Underweight on Agilent Technologies, Raises Price Target to $135

Wall Street faced a downturn on Thursday as traders exercised caution ahead of Federal Reserve Chair Jerome Powell&#8217;s speech at the<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40466528/jackson-hole-preview-5-important-questions-ahead-of-jerome-powells-fed-speech"> Jackson Hole Symposium on Friday.</a>
Powell is anticipated to signal a potential rate cut in September, but market sentiment currently favors a smaller 25-basis-point reduction rather than a more substantial 50-basis-point cut.
On Thursday, economic data indicated that U.S. private sector activity surpassed expectations in August, according to the S&amp;P Global flash Purchasing Managers&#8217; Index (PMI). The growth was primarily driven by the services sector, which more than compensated for <a href="https://www.benzinga.com/news/24/08/40509090/august-services-growth-exceeds-expectations-as-manufacturing-slumps-inflation-gradually-eases-to-nor">the faster contraction in manufacturing.</a>
Major U.S. equity indices traded lower throughout the session, while the dollar and Treasury yields rebounded after four consecutive days of losses. 
The U.S. dollar rose nearly 0.4% against a basket of major currencies, and the yield on the 10-year Treasury note climbed six basis points. As a result, bonds fell, with the iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) dropping 1.2%.
The energy sector emerged as the day&#8217;s top performer, buoyed by a more than 2% surge in oil prices. In contrast, natural gas plunged over 6% due to higher-than-expected inventory builds.
Gold also took a hit, declining over 1% and falling below the $2,500 per ounce threshold, weighed down by the strength of the dollar and rising Treasury yields. 
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) fell 1% to $60,000, failing to keep up with the Wednesday&#8217;s bullish momentum, which saw the largest cryptocurrency rise 3.6%.
<h1 class="wp-block-heading">Thursday&#8217;s Performance In Major US Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>40,830.40</td>
<td>-0.1 %</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,172.03</td>
<td>-0.2%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,608.27</td>
<td>-0.2%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,735.54</td>
<td>-0.5%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated At 12:41 p.m. ET</figcaption></figure>
According to Benzinga Pro data: 
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;was 0.1% lower to $559.92.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;eased 0.1% to $408.78.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 0.4% to $480.73.</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) inched 0.2% lower to $215.03.</li>
<li>The Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) outperformed, by 0.6%. The Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) lagged, down by 0.8%.</li>
</ul>
<h3 class="wp-block-heading">Thursday&#8217;s Stock Movers</h3>
<ul>
<li>Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) plummeted 12% as the<a href="https://www.benzinga.com/top-stories/24/08/40511947/investors-are-further-confused-on-snowflake-one-analyst-says-they-know-why"> guidance disappointed despite the company</a> reported stronger-than-expected results last quarter.</li>
<li>Other stocks reacting to corporate earnings were Zoom Video Communications Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) up 13%; Synopsys Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) down 1.77%; Agilent Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) up 0.36%; Nordson Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDSN#NASDAQ">NDSN</a>) up 2.06%, Williams-Sonoma Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) down 7%; Viking Holdings Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIK#NYSE">VIK</a>), down 3.81% and BJs Wholesale Club Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>), down 6.29%.</li>
<li>Major companies slated to report quarterly results after the close include Intuit Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>), Workday Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>), Ross Stores Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROSS#NASDAQ">ROSS</a>), CAVA Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>) and BILL Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BILL#NYSE">BILL</a>). </li>
</ul>
Read Now:
<ul>
<li><a href="https://www.benzinga.com/markets/esg/24/08/40512436/rivian-hits-rough-patch-production-halts-leadership-shake-ups-dent-stock">Rivian Hits Rough Patch: Production Halts, Leadership Shake-Ups Dent Stock</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Macro Economic Events

Sector ETFs

Bonds

Broad U.S. Equity ETFs

Commodities

Treasuries

Economics

Federal Reserve

ETFs

$BTC

BILL

CAVA

SPDR Dow Jones Industrial Average ETF Trust

INTU

NDSN

ROSS

SNPS

iShares Trust Barclays 20+ Year Treasury Bond Fund

WDAY

US Stocks Fall As Dollar, Treasury Yields Rise Ahead Of Fed's Jackson Hole; Oil Rebounds: What's Driving Markets Thursday?

Agilent Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) posted better-than-expected third-quarter earnings and issued upbeat<a href="https://www.benzinga.com/news/earnings/24/08/40507929/agilent-navigates-market-challenges-q3-exceeds-expectations-as-strategic-investments-pay-off"> fourth-quarter guidance on Wednesday.</a>
Revenue fell 5.6% Y/Y to $1.58 billion, beating the consensus of $1.56 billion. By segment, the Life Sciences and Applied Markets Group (LSAG) segment reported revenue of $782 million, down 8% Y/Y (-7% Y/Y core), with an operating margin of 28.4%. Adjusted EPS of $1.32 surpassed the street view of $1.26.
Agilent said it sees fourth-quarter revenue of $1.641 billion – $1.691 billion (vs. $1.67 billion estimate) and adjusted EPS of $1.38 – $1.42 (vs. street view of $1.44).
For FY24, Agilent revised its revenue outlook to $6.45 billion – $6.5 billion from $6.42 billion – $6.5 billion (vs. $6.46 billion estimate) and adjusted EPS to $5.21 – $5.25 (vs. $5.20 estimate) from $5.15 – $5.25 earlier.
Agilent President and CEO Padraig McDonnell said, "While market conditions continued to be challenged during the quarter, we saw steady signs of improvement as anticipated. We continue to make investments in our most promising growth opportunities."
Agilent shares gained 0.8% to trade at $141.17 on Thursday.
These analysts made changes to their price targets on Agilent following earnings announcement.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5874f5e55064ed0001eb1bcb/derik-de%20bruin">B of A Securities analyst Derik De Bruin</a> maintained Agilent with a Neutral and raised the price target from $140 to $147.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/586cf167351b9b0001a30547/vijay-kumar">Evercore ISI Group analyst Vijay Kumar</a> maintained the stock with an In-Line and raised the price target from $130 to $135.</li>
<li>TD Cowen analyst Dan Brennan maintained Agilent with a Buy and boosted the price target from $153 to $160.</li>
<li>Citigroup analyst <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5874f5e55064ed0001eb1bcb/derik-de%20bruin">Patrick Donnelly</a> maintained the stock with a Buy, while increasing the price target from $150 to $165.</li>
</ul>
Considering buying A stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="534" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/22120724/image-201-1024x534.png" alt="" class="wp-image-509093" style="width:531px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/22120724/image-201-1024x534.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/22120724/image-201-300x156.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/22120724/image-201-768x400.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/22120724/image-201.png 1287w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>

These Analysts Boost Their Forecasts On Agilent After Strong Earnings

Citigroup analyst Patrick Donnelly maintains Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) with a Buy and raises the price target from $150 to $165.

Citigroup Maintains Buy on Agilent Technologies, Raises Price Target to $165

TD Cowen analyst Dan Brennan maintains Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) with a Buy and raises the price target from $153 to $160.

TD Cowen Maintains Buy on Agilent Technologies, Raises Price Target to $160

Agilent Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) shares are trading higher after the company <a target="_blank" href="https://www.benzinga.com/pressreleases/24/08/b40494008/agilent-reports-third-quarter-fiscal-year-2024-financial-results" rel="noreferrer noopener">reported third-quarter results yesterday</a>.
Revenue fell 5.6% Y/Y to $1.58 billion, beating the consensus of $1.56 billion. By segment, the Life Sciences and Applied Markets Group (LSAG) segment reported revenue of $782 million, down 8% Y/Y (-7% Y/Y core), with an operating margin of 28.4%.
The Agilent CrossLab Group (ACG) revenue came in at $411 million, up 4% Y/Y (+5% Y/Y core), with an operating margin of 34.0%.
The Diagnostics and Genomics Group (DGG) revenue stood at $385 million, down 9% Y/Y (-8% Y/Y core), with an operating margin of 18.3%.
As of July 31, cash and cash equivalents stood at $1.78 billion. Adjusted EPS of $1.32 surpassed<a href="https://www.benzinga.com/earnings" target="_blank" rel="noreferrer noopener"> the street view of $1.26</a>.
Outlook: Agilent forecasts fourth-quarter revenue of $1.641 billion &#8211; $1.691 billion (vs. $1.67 billion estimate) and adjusted EPS of $1.38 &#8211; $1.42 (vs. street view of $1.44).
For FY24, Agilent revised its revenue outlook to $6.45 billion &#8211; $6.5 billion from $6.42 billion &#8211; $6.5 billion (vs. $6.46 billion estimate) and adjusted EPS to $5.21 &#8211; $5.25 (vs. $5.20 estimate) <a target="_blank" href="https://www.benzinga.com/news/earnings/24/05/39075050/agilent-technologies-stock-sinks-after-company-cuts-guidance-to-reflect-slower-market-recovery" rel="noreferrer noopener">from $5.15 &#8211; $5.25 earlier</a>.
Agilent President and CEO Padraig McDonnell said, &#8220;While market conditions continued to be challenged during the quarter, we saw steady signs of improvement as anticipated. We continue to make investments in our most promising growth opportunities.&#8221;
&#8220;And we are mobilizing the organization to accelerate value creation through strategic transformation initiatives, which will drive margin expansion and growth—and increase our execution capabilities.&#8221;
Investors can gain exposure to the stock via&nbsp;ProShares Nanotechnology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TINY#NYSE">TINY</a>) and VanEck ETF Trust VanEck Morningstar Wide Moat Growth ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/MGRO#BATS">MGRO</a>).
Price Action: A shares are up 1.88% at $142.63 at the last check Thursday.
Image from Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/40503213" target="_blank" rel="noreferrer noopener">EHang Q2 Revenue Skyrockets 920% with Record eVTOL Deliveries: Details</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

MGRO

TINY

Agilent Navigates Market Challenges: Q3 Exceeds Expectations As Strategic Investments Pay Off

WIIM

Agilent Technologies shares are trading higher after B of A Securities and Evercore ISI Group raised their respective price targets on the stock.

Evercore ISI Group analyst Vijay Kumar maintains Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) with a In-Line and raises the price target from $130 to $135.

Evercore ISI Group Maintains In-Line on Agilent Technologies, Raises Price Target to $135

B of A Securities analyst Derik De Bruin maintains Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) with a Neutral and raises the price target from $140 to $147.

B of A Securities Maintains Neutral on Agilent Technologies, Raises Price Target to $147

Index futures trading point to a slightly positive start on Thursday, with some key Main Street data likely directing the market. Sentiment could remain guarded as traders look ahead to the 3-day Jackson Hole Symposium that kickstarts on Thursday, with Federal Reserve Chairman Jerome Powell delivering his address on Friday. Earnings news has been mixed. With traders baking in a September rate cut, the near-term catalyst is likely to be Nvidia, Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) earnings due next week.
&#8220;Move over, Fed, it's all about Nvidia's earnings on August 28th. The waiting is the hardest part,&#8221; said Gina Bolvin, President of Bolvin Wealth Management Group.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>+0.07%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>+0.06%</td>
</tr>
<tr>
<td>Dow</td>
<td>+0.07%</td>
</tr>
<tr>
<td>R2K</td>
<td>+0.20%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Thursday,&nbsp;the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) climbed 0.16% to $561.50, and the&nbsp;Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) gained 0.18% to $483.38, according to&nbsp;<a href="https://benzinga.grsm.io/lxquj26b2sag" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.
Cues From Last Session: 
U.S. stocks ended Wednesday&#8217;s session higher, rebounding from the previous session&#8217;s slide, as traders relished the dovish message from the Federal Open Market Committee&#8217;s July meeting minutes and the Bureau of Labor Statistics&#8217; annual revision taking down the non-farm payroll numbers sharply.
The Nasdaq Composite and the S&amp;P 500 Index stayed mostly above the unchanged line, while the Dow Jones Industrial Average was relatively more volatile. All three closed firmly in the green. Small-caps outperformed the major indices, with the Russell 2,000 advancing 1.32%.
The S&amp;P 500 is now closing in on its all-time high of 5,667.20 hit on July 16 and the Nasdaq Composite ended at its highest levels since July 17.
Most S&amp;P 500 sectors, baring energy and financials, ended higher for the day, with consumer discretionary and material stocks seeing particular strength.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>+0.57%</td>
<td>17,918.99</td>
</tr>
<tr>
<td>S&amp;P 500 Index</td>
<td>+0.42%</td>
<td> 5,620.85</td>
</tr>
<tr>
<td>Dow Industrials</td>
<td>+0.14%</td>
<td>40,890.49</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>+1.32%</td>
<td>2,170.56</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
In a report released ahead of BLS&#8217; annual revision, Morgan Stanley&#8217;s Lisa Shalett said Wall Street analysts' current profit estimates appear ambitious, calling for accelerating and double-digit growth rates over the next six quarters, even as margins are already near record highs.
She said slowing nominal GDP will hurt companies&#8217; pricing power and profitability, adding that gains from falling costs and the advantages of a strong U.S. dollar may also fade. If companies choose to cut labor, in response, and job losses rise significantly, it could put the soft landing at risk, she added.
Carson Group&#8217;s Ryan Detrick noted that the S&amp;P 500 Index has been above the 200-day moving average for more than 200 days now. This has happened three times in the past and on those three instances, the index stayed above the 200-day MA for another 277 days, 242 days, and 195 days, he said. &#8220;If you are bearish b/c this is a long rally, be careful,&#8221; he added.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">S&amp;P 500 above the 200-day MA for more than 200 days (ok 201 to be exact). Sounds like a lot, right? Past 3 times it got to 200 days it stayed above for another 277 days, 242 days, and 195 days. In other words, if you are bearish b/c this is a long rally, be careful. <a href="https://t.co/43AgD1RQUD">pic.twitter.com/43AgD1RQUD</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1826462026203308204?ref_src=twsrc%5Etfw">August 22, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Upcoming Economic Data
<ul>
<li>The Labor Department is scheduled to release the weekly jobless claims report at 8:30 a.m. EDT. Economists, on average, expect the number of individuals claiming unemployment benefits to come in at 230,000 for the week ended Aug. 17, up from 227,000 in the previous reporting week.</li>
<li>S&amp;P Global will release its flash manufacturing and service sector purchasing managers&#8217; indices for August at 9:45 a.m. EDT. The consensus estimates call for the manufacturing PMI to edge down from 49.6 in July to 49.5 in August, and the service PMI is expected at 54 for August, down from 55 in July.</li>
<li>The National Association of Realtors is due to release the existing home sales report for July at 10 a.m. EDT. Existing home sales may have come in at a seasonally adjusted annual rate of 3.94 million units for July, up from June&#8217;s 3.89 million units.</li>
<li>The Treasury will auction four- and eight-week notes at 11:30 a.m. EDT and 30-year TIPS at 1 p.m. EDT.</li>
</ul>
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How To Trade Futures </a>
Stocks In Focus:
<ul>
<li>Agilent Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) rose over 2% <a href="https://www.benzinga.com/premarket">in premarket trading</a> following the company&#8217;s quarterly results announcement. </li>
<li>Among the other stocks moving on earnings are Urban Outfitters, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) (down over 10%), Snowflake Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) )down over 9%), Zuora, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZUO#NYSE">ZUO</a>) (up over 7.50%), Wolfspeed, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) (up over 8%), Synopsys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) (up over 2%), and Zoom Video Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) (up over 3.50%).</li>
<li>Advance Auto Parts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>), Baidu, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>), Bilibili Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BILI#NASDAQ">BILI</a>), NetEase, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTES#NASDAQ">NTES</a>), BJ&#8217;s Wholesale Club Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>), Canadian Solar Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSIQ#NASDAQ">CSIQ</a>), Peloton Interactive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTON#NASDAQ">PTON</a>) and Williams-Sonoma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) are among the <a href="https://www.benzinga.com/calendars/earnings">notable companies due to release their quarterly results</a> before the market opens.</li>
<li>Those reporting earnings after the close include BILL Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BILL#NYSE">BILL</a>), CAVA Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>), Intuit Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>), Ross Stores, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) and Workday, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>).</li>
<li>Charles Schwab Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) <a href="https://www.benzinga.com/markets/equities/24/08/40500034/charles-schwab-shares-drop-over-4-after-hours-as-td-bank-cuts-stake-following-2-6b-anti-money-la">slipped over 4% </a>after Toronto-Dominion Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TD#NYSE">TD</a>) sold shares in the former to provision for $2.6 billion in potential fines from U.S. regulators.</li>
</ul>
Commodities, Bonds And Global Equity Markets:
Crude oil futures rose marginally, while gold futures slipped further away from their record high. Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) rose following the FOMC minutes and approached the $61K level and the yield on the 10-year Treasury note rose 4.2 basis points to 3.818%.
The Asian markets had a mixed session, while European stocks were higher in early trading on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40501889/nvidia-stock-to-surge-to-340-in-medium-term-portfolio-manager-sees-strong-rally-int">Nvidia Stock To Surge To $340 In Medium Term? Portfolio Manager Sees Strong Rally Interspersed By 35-80% Pullbacks</a></li>
</ul>
Photo via Shutterstock

Futures

Previews

US Stocks Poised For Tepid Start Ahead Of Private Sector Activity Data And Jackson Hole Symposium: Analyst Says Market Is Focused On Nvidia Earnings And 'Waiting Is The Hardest Part'

Comments

Agilent Technologies

매도 수량

Agilent Technologies (NYSE:A) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌